International Clinical Trial: Comparative Efficacy of Alpha Hydroxy Acids With and Without Nanocarriers Versus Calcipotriol Plus Betamethasone in Treatment of Plaque Psoriasis

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07816575) titled 'Comparative Efficacy of Alpha Hydroxy Acids With and Without Nanocarriers Versus Calcipotriol Plus Betamethasone in Treatment of Plaque Psoriasis' on Sept. 8.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Al-Azhar University

Condition: Psoriasis

Intervention: Drug: Alpha Hydroxy Acids with nanocarriers Drug: Alpha Hydroxy Acids only. Drug: Calcipotriol plus betamethasone

Recruitment Status: Not recruiting

Phase: N/A

Date ...